Renowned University Medical Center goes Live with LABVANTAGE 6
News Mar 22, 2012
LABVANTAGE announced that a world-renowned university medical center is live with its laboratory information management system (LIMS). Consisting of over 10 core laboratories, the institute processes an extremely high volume of samples for RNAi, genomics testing, small animal imaging, transgenics, proteomics, flow cytometry, microscopy, and more. The center required a reliable and powerful application to manage their processes from submission to billing for multiple hospitals and research units. The LABVANTAGE system fulfilled these needs and implemented this highly tailored solution on an aggressive timeline.
The solution that emerged from the LABVANTAGE early access module called StoreFront integrates LABVANTAGE with PeopleSoft for financials, InfoEd for electronic research administration, and Topaz for clinical protocol management. LABVANTAGE StoreFront provides administration functionality for service management, request and submission management, scheduling, data delivery, and invoicing and billing for all cores.
“The LABVANTAGE StoreFront functionality had previously been implemented by our professional services organization at other leading academic organizations,” says Jeff Ferguson, LABVANTAGE Chief Executive Officer. “This early access project provided a great opportunity for LABVANTAGE to incorporate the StoreFront functionality as part of the LABVANTAGE 6 release. It is a great tribute to the collaboration of the client and LABVATAGE teams that this complex system could be brought into production within eight weeks of the LABVANTAGE 6 product release.”
In this initial phase, the LABVANTAGE StoreFront went live on the Apple Safari browser and included complex instrument integration, interfacing to numerous external systems, advanced reporting and analytics. Moving forward, subsequent phases will include the implementation of the LABVANTAGE BioBanking solution to manage the center’s multiple biorepositories.
LifeArc and Milner Therapeutics Institute Announce a New Partnership in AI for Target DiscoveryNews
LifeArc®, the UK-based medical research charity, and the Milner Therapeutics Institute at the University of Cambridge, today announced a new partnership to identify and validate new drug targets in immuno-oncology and respiratory diseases.READ MORE
Drug-like Compounds Reverse Chemotherapy Failure for 3 Aggressive CancersNews
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers -- ovarian, prostate and breast.READ MORE
Algorithm Unearths Over 1000 Antibiotic Proteins in a Few HoursNews
The algorithm identified 10 times more peptide variations than all previous discoveries combined, aiding the hunt for new antibiotics.READ MORE